For technical support please reach out to us at: 877-940-6144 or info@flhie.org. 

Patients may select:

• No expiration date, or
• A specific expiration period

Consent remains in effect until it expires or is revoked.

Yes. Patients may revise or revoke their consent at any time.
When revoked, the HIE immediately stops sharing the SUD/MH data going forward. However, previously shared data cannot be retrieved.

Users with appropriate permissions can access the tool through:

• The HIE Portal
• The InContext App (embedded in the user’s EHR)
• The Telehealth Consent Form, which allows remote consent when patients are not physically present
• If you do not see the Consent Tool in your HIE Portal, your organization’s HIE administrator can assign access.

Any member of a patient’s care team may register consent, including:

• Social workers
• Care coordinators
• Nurses
• Case managers
• Primary care physicians
• Part 2 providers

Consent can be registered:

• During in-person visits, where the patient signs directly within the tool
• During telehealth encounters, after which a credentialed staff member may register the consent online by attesting that a signed form exists on file
• Through EHR single sign-on (SSO), launching the Consent Tool directly from the provider’s workflow

Patients may choose what level of information to share, including:

• SUD/MH provider contact information only, or
• All SUD/MH clinical data, which may include treatment plans, medications, labs, clinical notes, and more

All shared data is accompanied by a Part 2 warning indicating it may not be redisclosed except as permitted by law.

The Consent Tool is a consent management application used to register patient consent for sharing specific protected data types — most notably Substance Use Disorder (SUD) and Mental Health (MH) information which is protected under 42 CFR Part 2. With documented patient consent, this sensitive behavioral health data can be shared with members of the patient’s extended care team through the HIE.

While participation in the HIE is generally on an optout basis for most clinical data, SUD/MH information is treated differently and sharing of this data requires affirmative, explicit patient consent.
The Consent Tool:

• Ensures compliance with 42 CFR Part 2
• Improves care coordination between SUD/MH providers and the broader care team
• Reduces workflow burden associated with obtaining and documenting consent